Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
Drug Deliv. 2020 Dec;27(1):128-136. doi: 10.1080/10717544.2019.1709919.
Receptor-mediated active targeting and tumor microenvironment responsive systems from polymeric micelles have been studied for rapid cellular internalization and triggered drug release. Previously we have constructed redox-responsive polymeric micelles composed of vitamin E succinate conjugated hyaluronic acid (HA-ss-TOS), which are able to actively target CD44 proteins and quickly release loaded drugs upon exposure to high levels of glutathione (GSH) in tumor cells. In the present study, we found that despite different cellular internalization mechanisms, micelles showed strong antineoplastic effects on 4T1 and B16F10 cells due to redox responsiveness. HA-ss-TOS-PTX micelles exhibited an excellent tumor targeting ability and prolonged retention time compared to Taxol . In addition, a superior antitumor effect was achieved compared to PTX-loaded insensitive micelles (HA-TOS-PTX) and Taxol. Our results revealed that PTX-loaded HA-ss-TOS micelles could enhance the antineoplastic efficacy of PTX for breast cancer and melanoma treatment and, thus, deserve further attention.
聚合物胶束的受体介导的主动靶向和肿瘤微环境响应系统已被研究用于快速细胞内化和触发药物释放。 此前,我们构建了由琥珀酸维生素 E 共轭透明质酸(HA-ss-TOS)组成的氧化还原响应性聚合物胶束,该胶束能够主动靶向 CD44 蛋白,并在暴露于肿瘤细胞中高浓度谷胱甘肽(GSH)时迅速释放负载的药物。 在本研究中,我们发现,尽管存在不同的细胞内化机制,但由于氧化还原响应性,胶束对 4T1 和 B16F10 细胞表现出很强的抗肿瘤作用。与 Taxol 相比,HA-ss-TOS-PTX 胶束表现出优异的肿瘤靶向能力和延长的保留时间。 此外,与载药不敏感胶束(HA-TOS-PTX)和 Taxol 相比,还实现了更好的抗肿瘤效果。 我们的结果表明,载药 HA-ss-TOS 胶束可以增强 PTX 对乳腺癌和黑色素瘤治疗的抗肿瘤功效,因此值得进一步关注。